-denoson
Drugs that activate adenosine receptors.
- Drugs ending in -denoson: 11
- Approved somewhere: 1
- With a US drug page: 0
- Stem
- -denoson
- Class
- Drugs that activate adenosine receptors
Approved and clinical-stage drugs in ChEMBL whose names ending in -denoson, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Regadenoson anhydrous | Approved | ADORA2A | Adenosine A2a receptor agonist |
| Piclidenoson | Phase 3 | ADORA3 | Adenosine A3 receptor agonist |
| Trabodenoson | Phase 3 | ADORA1 | Adenosine A1 receptor agonist |
| Capadenoson | Phase 2 | ADORA1 | Adenosine A1 receptor partial agonist |
| Namodenoson | Phase 2 | ADORA3 | Adenosine A3 receptor agonist |
| Selodenoson | Phase 2 | ADORA1 | Adenosine A1 receptor agonist |
| Sonedenoson | Phase 2 | ADORA2A | Adenosine A2a receptor agonist |
| Tecadenoson | Phase 2 | ADORA1 | Adenosine A1 receptor agonist |
| Evodenoson | Phase 1 | ADORA2A | Adenosine A2a receptor agonist |
| Apadenoson | — | ADORA2A | Adenosine A2a receptor agonist |
| Binodenoson | — | ADORA2A | Adenosine A2a receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO